Armata Pharmaceuticals (ARMP) EBT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 47.45% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 12.01% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -1.05% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 20.92% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 48.67% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | -8.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.19% |
| Dec 31, 2025 | -21.84% |
| Sep 30, 2025 | -12.06% |
| Jun 30, 2025 | -4.95% |
| Mar 31, 2025 | -10.36% |
| Dec 31, 2024 | -31.72% |
| Sep 30, 2024 | -27.31% |
| Jun 30, 2024 | -32.51% |
| Mar 31, 2024 | -29.72% |
| Dec 31, 2023 | -18.71% |
| Sep 30, 2023 | -25.73% |
| Jun 30, 2023 | -26.71% |
| Mar 31, 2023 | -30.66% |
| Dec 31, 2022 | -31.02% |
| Sep 30, 2022 | -7.39% |
| Jun 30, 2022 | -29.95% |
| Mar 31, 2022 | -33.36% |
| Dec 31, 2021 | -76.43% |
| Sep 30, 2021 | -30.41% |
| Jun 30, 2021 | -25.06% |
| Mar 31, 2021 | -21.61% |
| Dec 31, 2020 | -49.63% |
| Sep 30, 2020 | -94.92% |
| Jun 30, 2020 | 15.34% |
| Mar 31, 2020 | -14.76% |
| Dec 31, 2019 | -52.39% |
| Sep 30, 2019 | -43.07% |
| Jun 30, 2019 | -2.93% |
| Mar 31, 2019 | 6.45% |
| Dec 31, 2018 | 27.92% |
| Sep 30, 2018 | -6.42% |
| Jun 30, 2018 | -6.91% |
| Mar 31, 2018 | -4.23% |
| Dec 31, 2017 | 56.99% |
| Sep 30, 2017 | 46.99% |
| Jun 30, 2017 | -27.47% |
| Mar 31, 2017 | 33.27% |
| Dec 31, 2016 | 46.63% |
| Sep 30, 2016 | -0.35% |
| Jun 30, 2016 | 14.92% |